Have a feature idea you'd love to see implemented?
Let us know!
THRD Third Harmonic Bio Inc
Price (delayed)
$13.07
Market cap
$537.14M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.82
Enterprise value
$284.95M
Highlights
Third Harmonic Bio's debt has decreased by 16% YoY and by 4.8% QoQ
The company's net income fell by 11% QoQ but it rose by 10% YoY
THRD's quick ratio is down by 39% year-on-year and by 39% since the previous quarter
The company's EPS fell by 9% QoQ
Key stats
What are the main financial stats of THRD
Market
Valuations
Earnings
Shares outstanding
41.1M
Market cap
$537.14M
Enterprise value
$284.95M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.08
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$32.74M
EBITDA
-$32.01M
Free cash flow
-$24.89M
Per share
Balance sheet
Liquidity
EPS
-$0.82
Free cash flow per share
-$0.61
Book value per share
$6.27
Revenue per share
$0
TBVPS
$6.56
Total assets
$265.86M
Total liabilities
$9.14M
Debt
$3.59M
Equity
$256.71M
Working capital
$254.88M
Debt to equity
0.01
Current ratio
41.13
Quick ratio
40.27
Net debt/EBITDA
7.88
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-11.9%
Return on equity
-12.3%
Return on invested capital
-481.7%
Return on capital employed
-12.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
THRD stock price
How has the Third Harmonic Bio stock price performed over time
Intraday
0.85%
1 week
-0.31%
1 month
-6.58%
1 year
95.95%
YTD
19.14%
QTD
-3.54%
Financial performance
How have Third Harmonic Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$46.61M
Net income
-$32.74M
Gross margin
N/A
Net margin
N/A
The company's net income fell by 11% QoQ but it rose by 10% YoY
THRD's operating income is down by 8% since the previous quarter and by 4% year-on-year
Growth
What is Third Harmonic Bio's growth rate over time
Valuation
What is Third Harmonic Bio stock price valuation
P/E
N/A
P/B
2.08
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 9% QoQ
The stock's price to book (P/B) is 39% more than its last 4 quarters average of 1.5
The equity fell by 8% YoY and by 2.6% QoQ
Efficiency
How efficient is Third Harmonic Bio business performance
THRD's ROIC is up by 25% YoY but it is down by 11% from the previous quarter
The return on equity has declined by 13% since the previous quarter but it rose by 3.1% year-on-year
THRD's return on assets is down by 12% since the previous quarter but it is up by 3.3% year-on-year
Dividends
What is THRD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for THRD.
Financial health
How did Third Harmonic Bio financials performed over time
THRD's quick ratio is down by 39% year-on-year and by 39% since the previous quarter
THRD's current ratio is down by 38% year-on-year and by 38% since the previous quarter
Third Harmonic Bio's debt is 99% lower than its equity
The company's debt to equity has shrunk by 50% YoY
Third Harmonic Bio's debt has decreased by 16% YoY and by 4.8% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.